Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial "WARCEF"

Completed

Phase 3 Results

Summary of Purpose

The purpose of this study is to determine which of two treatments, Warfarin or aspirin, is better for preventing death and stroke in patients with poor heart function. We are now transitioning into the sub-analysis part of the WARCEF patient data. The study has recently completed data analysis for its Primary Aim. All randomized patients have completed their follow up. All study related procedure as per the...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 29 August 2014.

1 Oct 2002 19 Jul 2002 1 Aug 2011 1 Jul 2014 1 Aug 2014 3 Jan 2013
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator)
  • Purpose: Prevention
  • Intervention: Parallel Assignment

Contacts

  • Vilma Mejia at 212-342-6058 or at: vm2181@columbia.edu

    vm2181@columbia.edu